Table VII.
Relationship between IL-17 and pro-inflammatory complications.
| IL-17, Day 1a | IL-17, mediana | |||||
|---|---|---|---|---|---|---|
| Complications | ≤45 pg/ml | >45 pg/ml | P-value | ≤90 pg/ml | >90 pg/ml | P-value |
| PC | 0.009 | <0.001c | ||||
| PC | 28 | 123 | 29 | 122 | ||
| Non-PC | 50 | 109 | 61 | 98 | ||
| ISS | 23.4±10.6 | 29.1±11.1 | <0.001 | 23.8±10.5 | 29.2±11.2 | <0.001c |
| ARDS | 0.018 | 0.036b | ||||
| ARDS | 4 | 36 | 6 | 34 | ||
| Non-ARDS | 74 | 196 | 84 | 186 | ||
aMean ± standard deviation or n;
bP<0.05;
cP<0.001. IL, interleukin; PC, pulmonary contusion; ISS, injury severity score; ARDS, acute respiratory distress syndrome; IL-17 Day 1, plasma level of IL-17 on the day when patients were admitted to the hospital; IL-17 median, plasma level of IL-17 on all 7 days after trauma.